How Procter & Gamble Pulled Off an Excellent Q4

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
How Procter & Gamble Pulled Off an Excellent Q4

© Public Domaine / Wikimedia Commons

Procter & Gamble Co. (NYSE: PG | PG Price Prediction) released its fourth-quarter earnings report before the markets opened on Wednesday. The company said that it had $1.25 in earnings per share (EPS) and $17.44 billion in revenue, which compares with consensus estimates of $1.21 in EPS and revenue of $17.15 billion. In the same period of last year, the consumer products giant said it had EPS of $1.19 on $17.39 billion in revenue.

During the most recent quarter, Procter & Gamble returned $2.6 billion of cash to shareholders via nearly $1.9 billion of dividend payments and $0.8 billion of common stock repurchases.

In terms of its segments, the firm reported:

  • Beauty net sales increased 4% year over year to $3.36 billion.
  • Grooming net sales decreased 9% to $1.62 billion.
  • Health Care net sales came in at $2.22 billion.
  • Fabric & Home Care net sales increased 2% to $5.56 billion.
  • Baby, Feminine & Family Care net sales decreased 1% to $4.56 billion.
  • Corporate net sales increased 2% to $129 million.

[nativounit]

Looking ahead to the 2019 full year, the company expects to see organic sales growth in the range of 2% to 4% and core EPS growth of roughly 8%. Consensus estimates call for $4.74 in EPS and $68.89 billion in revenue for the year.

David Taylor, board chair, president and CEO, commented:

We delivered strong organic sales in the second quarter, building on our first quarter momentum, which enables us to increase our outlook for the year. Our focus on superiority, productivity and improving P&G’s organization and culture is delivering improved results despite a challenging competitive and macroeconomic environment.

Shares of Procter & Gamble closed Tuesday at $90.44, in a 52-week range of $70.73 to $96.90. The consensus analyst price target is $93.33. Following the announcement, the stock was up about 4% at $94.19 in early trading indications Wednesday.

[recirclink id=523223]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618